Diabetic ketoacidosis (DKA): treatment guidelines

Related Experiment Video

Updated: Aug 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A L Rosenbloom1, R Hanas

  • 1Department of Pediatrics, University of Florida College of Medicine, Gainesville 32610-0296, USA.

Clinical Pediatrics
|May 1, 1996
PubMed

Insights

Diabetic ketoacidosis (DKA) in children requires prompt management to restore perfusion, correct electrolytes, and prevent complications like cerebral edema. Prevention through close supervision and early diabetes detection is crucial.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Critical Care Medicine

Background:

  • Diabetic ketoacidosis (DKA) is a severe complication of diabetes mellitus, primarily caused by insulin deficiency.
  • DKA is a leading cause of hospitalization and mortality in children with diabetes, with cerebral edema being a significant risk.
  • Understanding DKA's pathophysiology is vital for effective pediatric diabetes management.

Purpose of the Study:

  • To provide comprehensive guidelines for the management of diabetic ketoacidosis in pediatric patients.
  • To outline strategies for preventing DKA and its associated complications, particularly cerebral edema.
  • To emphasize critical monitoring parameters and timely interventions in DKA management.

Main Methods:

  • Review and synthesis of current literature and clinical practices for DKA management in children.
  • Development of evidence-based recommendations for fluid resuscitation, insulin therapy, and electrolyte correction.
  • Identification of risk factors and preventive measures for DKA, including patient and family education.

Main Results:

  • Guidelines focus on restoring perfusion, halting ketogenesis, and correcting electrolyte imbalances while avoiding hypokalemia and hypoglycemia.
  • Emphasis on vigilant monitoring of glycemia, electrolytes, hydration, vital signs, and neurological status.
  • Strategies for managing potential complications like cerebral edema, including the use of mannitol.

Conclusions:

  • Effective DKA management in children requires a multi-faceted approach addressing metabolic derangements and preventing complications.
  • Prevention strategies are paramount, involving close supervision of established diabetic patients and early diagnosis in new cases.
  • A high index of suspicion for diabetes in at-risk children, especially those under five, is essential to prevent severe outcomes.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas04:41

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas

Published on: July 25, 2025

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...